Ignite Creation Date:
2024-10-26 @ 3:40 PM
Last Modification Date:
2024-10-26 @ 3:40 PM
Study NCT ID:
NCT06590857
Status:
RECRUITING
Last Update Posted:
None
First Post:
2024-09-03
Brief Title:
Trial of 225Ac-DOTATATE RYZ101 Alone and with Pembrolizumab in Subjects with ER HER2-negative Unresectable or Metastatic Breast Cancer Expressing SSTRs
Sponsor:
Organization:
None